Literature DB >> 34649356

Oligonucleotide aptamers: Recent advances in their screening, molecular conformation and therapeutic applications.

Xueran Xiao1, Hui Li2, Lijian Zhao1, Yanfen Zhang3, Zhongcheng Liu4.   

Abstract

Aptamers are single stranded oligonucleotides with specific recognition and binding ability to target molecules, which can be obtained by Systematic Evolution of Ligands by Exponential Enrichment (SELEX). Aptamers have the advantages of low molecular weight, low immunogenicity, easy modification and high stability. They play promising role in promoting food safety, monitoring the environment and basic research, especially in clinical diagnosis and therapeutic drugs. To date, great achievements regarding the selection, modifications and application of aptamers have been made. However, since it is still a challenge to obtain aptamers with high affinity in a more effective way, few aptamer-based products have already successfully entered into clinical use. This review aims to provide a thorough overview of the latest advances in this rapidly developing field, focusing on aptamer screening methods for different targets, the structure of the interaction between aptamers and target substances, and the challenges and potential of current therapeutic aptamers.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Aptamer; Clinical trials; Nucleic acid drug; SELEX; Screening method

Mesh:

Substances:

Year:  2021        PMID: 34649356     DOI: 10.1016/j.biopha.2021.112232

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  4 in total

1.  An electrochemical aptasensor based on target triggered multiple-channel DNAzymes cycling amplification strategy with PtFe@Co-MOF as signal amplifier.

Authors:  Tong Zhu; Na Li; Jiangjian Huang; Xiaohansi Xu; Xin Su; Yi Ma; Renxiang Yang; Jia Ruan; Huilan Su
Journal:  Mikrochim Acta       Date:  2022-09-21       Impact factor: 6.408

Review 2.  An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology.

Authors:  Mina Roueinfar; Hayley N Templeton; Julietta A Sheng; Ka Lok Hong
Journal:  Molecules       Date:  2022-02-07       Impact factor: 4.411

Review 3.  Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy.

Authors:  Wenjing Xu; Chunping Ye; Xin Qing; Shengli Liu; Xinyi Lv; Wenjun Wang; Xiaochen Dong; Yewei Zhang
Journal:  Mater Today Bio       Date:  2022-07-12

Review 4.  Intranasal delivery: An attractive route for the administration of nucleic acid based therapeutics for CNS disorders.

Authors:  Pranav Shah; Manisha Lalan; Kalyani Barve
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.